Live Breaking News & Updates on Hematology Oncology Association

Stay updated with breaking news from Hematology oncology association. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NMDP to Present New Stem Cell Transplantation Data at the

NMDP to present new data on hematopoietic cell transplantation treatment effects in patients with hematological malignancies at ASCO. . ....

United States , Baylor College Of Medicine , Monzrm Al Malki , Samantha Watters , Rayneh Rouce , Stevenm Devine , Partow Kebriaei , International Blood , University Of Texas Md Anderson Cancer Center , College Of Wisconsin , Texas Children Cancer Center , Department Of Hematology Hematopoietic Cell Transplantation , International Blood Marrow Transplant Research , American Society Of Clinical Oncology , Marrow Transplant Research , Marrow Transplant , American Society , Clinical Oncology , Annual Meeting May , Chief Medical Officer , Senior Scientific Director , Medical College , Associate Professor , Hematopoietic Cell Transplantation , Oral Abstract , Hematologic Malignancies ,

#VisualAbstract: Imetelstat improves blood transfusion independence in lower-risk myelodysplastic syndromes

1. Significantly more patients in the imetelstat group achieved RBC transfusion independence at 8 weeks after treatment compared to placebo. 2. Grade 3-4 treatment-related adverse events were greater in the imetelstat group. Evidence Rating Level: 1 (Excellent) Study Rundown: Patients with red blood cell transfusion-dependent lower-risk myelodysplastic syndromes (LR-MDS) face unmet medical needs when unresponsive to erythropoiesis-stimulating ....

Blood Transfusion , Erythropoeisis Stimulating Agents Esas , Febrile Neutropenia , Myelodysplastic Syndrome , Myelodysplastic Syndromes ,

Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma

1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score < 7 and not receiving anticoagulation. 2. There was no significant difference between the control and intervention phases regarding secondary outcomes. Evidence Rating Level: 1 (Excellent) Study Rundown: Venous thromboembolism (VTE) is a well-recognized potential complication resulting from orthopedic trauma and ....

Rating Level , Thrombosis Risk Prediction , Cast Immobilization , Low Molecular Weight Heparin , Between Jun , Oral Anticoagulation , Lower Limb Injury , Lower Limb Trauma , Prophylactic Anticoagulation , Trip Cast Score , Venous Thromboembolism , Venous Thromboembolism Vte , Chronic Disease , Orthopedic Surgery ,

#VisualAbstract: Iptacopan improves hematologic and clinical outcomes in paroxysmal nocturnal hemoglobinuria

1. In two clinical trials, iptacopan in patients with paroxysmal nocturnal hemoglobinuria (PNH) improved hemoglobin levels compared to anti-C5-treated patients and those without complement inhibitors. 2. Patients who received iptacopan generally exhibited improved secondary outcomes, including less fatigue, reduced reticulocyte and bilirubin levels, and decreased breakthrough hemolysis. Evidence Rating Level: 1 (Excellent) Study Rundown: PNH is a ....

Paroxysmal Nocturnal Hemoglobinuria ,

Nebraska Community Blood Bank declares emergency due to low supply, urges donations

NCBB said that they are still recovering from a nearly 50% decrease in youth and first-time blood donors since 2019, and are working to rebuild donations. ....

United States , Cheryl Warholoski , Nebraska Community Blood Bank , Drug Administration , Executive Director , Nebraska Community Blood , Health Medical Pharma , Transfusion Medicine , Blood Donation , Blood Bank , Blood Donation In India , Blood Transfusion ,